Table 1 Comparative analysis of baseline data among the different groups of patients.
From: Impact of subcutaneous tunnel length on infection risk in tunneled PICCs: a study in cancer patient
Variables | A1 (n = 76) | A2 (n = 80) | A3 (n = 80) | A4 (n = 83) | A5 (n = 83) | t/χ2 | P |
|---|---|---|---|---|---|---|---|
Age, years | 51.88 ± 14.7 | 55.05 ± 9.52 | 54.99 ± 11.05 | 56.87 ± 10.19 | 54.04 ± 12.56 | 1.901 | 0.109 |
Gender | 14.185 | 0.007 | |||||
Male | 34 (44.7) | 39 (48.8) | 43 (53.8) | 31 (37.3) | 54 (65.1) | ||
Female | 42 (55.3) | 41 (51.2) | 37 (46.3) | 52 (62.7) | 29 (34.9) | ||
BMI, kg/m2 | 22.21 ± 2.94 | 23.08 ± 2.65 | 22.89 ± 2.77 | 22.56 ± 2.91 | 21.81 ± 2.9 | 2.661 | 0.032 |
Education level | 17.459 | 0.133 | |||||
Elementary school or below | 9 (11.8) | 6 (7.5) | 8 (10.0) | 9 (10.8) | 6 (7.2) | ||
Junior High | 19 (25.0) | 32 (40.0) | 28 (35.0) | 30 (36.1) | 19 (22.9) | ||
High School | 25 (32.9) | 28 (35.0) | 24 (30.0) | 18 (21.7) | 25 (30.1) | ||
College and Above | 23 (30.3) | 14 (17.5) | 20 (25.0) | 26 (31.3) | 33 (39.8) | ||
Previous Catheter History | – | – | |||||
No | 76 (100.0) | 80 (100.0) | 80 (100.0) | 83 (100.0) | 83 (100.0) | ||
Yes | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
Diabetes history | – | – | |||||
Yes | 1 (1.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
No | 75(98.7) | 80(100.0) | 80(100.0) | 83 (100.0) | 83 (100.0) | ||
Hypertension history | – | – | |||||
Yes | 1 (1.3) | 0 (0.0) | 0 (0.0) | 1 (1.3) | 0 (0.0) | ||
No | 75(98.7) | 80(100.0) | 80(100.0) | 83 (100.0) | 83 (100.0) | ||
Tumor type | 35.372 | 0.159 | |||||
Gynecological/Reproductive | 25 (32.9) | 28 (35.0) | 24 (30.0) | 39 (47.0) | 16 (19.5) | ||
Lung | 11 (14.5) | 17 (21.3) | 22 (27.5) | 22 (26.5) | 19 (23.2) | ||
Digestive system | 20 (26.3) | 18 (22.5) | 20 (25.0) | 10 (12.0) | 21 (25.6) | ||
Hematological | 4 (5.3) | 1 (1.3) | 2 (2.5) | 2 (2.4) | 5 (6.1) | ||
Orthopedic | 1 (1.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.2) | ||
Neurological | 3 (3.9) | 3 (3.8) | 0 (0.0) | 1 (1.2) | 1 (1.2) | ||
Urological | 2 (2.6) | 1 (1.3) | 1 (1.3) | 1 (1.2) | 3 (3.7) | ||
Others | 10 (13.2) | 12 (15.0) | 11 (13.8) | 8 (9.6) | 17 (20.5) | ||
Hb (g/L) | 133.16 ± 10.38 | 133.16 ± 11.1 | 131.29 ± 10.41 | 133.61 ± 10.39 | 132.78 ± 10.69 | 0.575 | 0.681 |
WBC (×109/L) | 6.65 ± 1.85 | 6.73 ± 1.67 | 6.75 ± 1.75 | 6.59 ± 1.77 | 6.3 ± 1.68 | 0.909 | 0.458 |
9RBC (×109/L) | 4.46 ± 0.35 | 4.45 ± 0.38 | 4.33 ± 0.39 | 4.44 ± 0.4 | 4.4 ± 0.38 | 1.533 | 0.192 |
9PLT (×10⁹/L) | 246.43 ± 66.36 | 235.41 ± 64.73 | 225.56 ± 63.06 | 236.35 ± 69.99 | 247.3 ± 65 | 1.480 | 0.207 |
9PT (s) | 12.71 ± 1.16 | 12.98 ± 1.23 | 12.9 ± 1.22 | 12.93 ± 1.05 | 12.96 ± 1.22 | 0.660 | 0.620 |
9APTT (s) | 35.98 ± 3.87 | 35.31 ± 4.2 | 35.66 ± 4.84 | 35.81 ± 4.02 | 36.68 ± 4.06 | 1.185 | 0.317 |
9Fbg (g/L) | 3.09 ± 0.6 | 2.98 ± 0.52 | 2.97 ± 0.55 | 2.98 ± 0.6 | 2.95 ± 0.6 | 0.690 | 0.600 |
9DD (µg/ml) | 0.23 ± 0.15 | 0.25 ± 0.14 | 0.23 ± 0.13 | 0.24 ± 0.14 | 0.24 ± 0.14 | 0.163 | 0.957 |
